Lifeboat Foundation

As the coming genetic revolution plays out, we’ll still have sex for most of the same reasons we do today. But we’ll increasingly not do it to procreate.

Another rocket booster will be the application of gene editing technologies like CRISPR to edit the genomes of pre-implanted embryos or of the sperm and eggs used to create them. Just this week, Chinese researchers announced they had used CRISPR to edit the CCR5 gene in the pre-implanted embryos of a pair of Chinese twins to make them immune to HIV, the first ever case of gene editing humans and a harbinger of our genetically engineered future. The astounding complexity of the human genome will put limits on our ability to safely make too many simultaneous genetic changes to human embryos, but our ability and willingness to make these types of alterations to our future children will grow over time along with our knowledge and technological ability.

Continue reading “Is Sex for Reproduction About to Become Extinct?” »

A is a piece of equipment seen in Call of Duty: Modern Warfare 2, Call of Duty: Black Ops and Call of Duty: Advanced Warfare, and usable in Call of Duty: Modern Warfare 3, Call of Duty Online, Call of Duty: Ghosts and Call of Duty: Heroes. Juggernauts are seen wearing the suits in the Special Ops levels “Snatch& Grab”, “Estate Takedown”, “High Explosive”, and “Armor Piercing”. A character with a juggernaut suit is also seen in “Museum”.

This can make even barren planets hospitable if a device is made like a magnetic field barrier.

New model explains the odd magnetic fields of Neptune and Uranus.

Find news on Lumen Couture unveils designs with cutting edge-technology and more fashion related news at Fibre2Fashion.

AI/Humans, our brave now world, happening now.

Are we facing a golden digital age or will robots soon run the world? We need to establish ethical standards in dealing with artificial intelligence — and to answer the question: What still makes us as human beings unique?

Continue reading “Artificial intelligence and its ethics | DW Documentary” »

It’s hard living in a relativistic Universe, where even the nearest stars are so far away and the speed of light is absolute. It is little wonder then why science fiction franchises routinely employ FTL (Faster-than-Light) as a plot device.

Push a button, press a petal, and that fancy drive system – whose workings no one can explain – will send us to another location in space-time.

However, in recent years, the scientific community has become understandably excited and skeptical about claims that a particular concept – the Alcubierre Warp Drive – might actually be feasible.

Honeywell, the same company that might make your humidifier or home security system, is unveiling a powerful quantum computer that will be available to the public.

Computer scientists from Rice, supported by collaborators from Intel, will present their results today at the Austin Convention Center as a part of the machine learning systems conference MLSys.

Many companies are investing heavily in GPUs and other specialized hardware to implement deep learning, a powerful form of artificial intelligence that’s behind digital assistants like Alexa and Siri, facial recognition, product recommendation systems and other technologies. For example, Nvidia, the maker of the industry’s gold-standard Tesla V100 Tensor Core GPUs, recently reported a 41% increase in its fourth quarter revenues compared with the previous year.

Rice researchers created a cost-saving alternative to GPU, an algorithm called “sub-linear deep learning engine” (SLIDE) that uses general purpose central processing units (CPUs) without specialized acceleration hardware.

Researchers report an advance in the development of a blood test that could help detect pathological Alzheimer’s disease in people who are showing signs of dementia. This approach could be less invasive and less costly than current brain imaging and spinal fluid tests. The blood test detects the abnormal accumulation of a form of tau protein known as phosphorylated-tau-181 (ptau181), which is a biomarker that suggests brain changes from Alzheimer’s. The study, funded by the National Institutes of Health, was published on March 2 in Nature Medicine.

Over the past 15 years, research advances in the development of biomarkers like tau protein have enabled investigators to more accurately diagnose Alzheimer’s disease, select research participants, and measure response to investigational therapies. Tau and other biomarkers can be detected with PET scans of the brain and lab tests of spinal fluid. However, PET imaging is expensive and involves radioactive agents, and spinal fluid tests require spinal taps, which are invasive, complex and time-consuming. Simpler biomarker tests are still needed.

“The considerable time and resources required for screening research participants with PET scans and spinal taps slow the pace of enrollment for Alzheimer’s disease treatment studies,” said Richard J. Hodes, M.D., director of NIH’s National Institute on Aging (NIA), which funded much of the study. “The development of a blood test would enable us to rapidly screen a much larger and more diverse group of volunteers who wish to enroll in studies.”